Skip to Content
Merck

GC Analysis of Fluoxetine Enantiomers (N-TFA Derivatives) on Astec® CHIRALDEX™ B-DA

GC Analysis of Fluoxetine Enantiomers (N-TFA Derivatives) on Astec® CHIRALDEX™ B-DA suitable for GC

Materials

standard

Product No.
Description
Pricing

F132

Fluoxetine hydrochloride

solid

F1553

S-(+)-Fluoxetine hydrochloride

≥98% (HPLC), solid

F1678

R-(−)-Fluoxetine hydrochloride

>98% (HPLC), solid

34012

Fluoxetine hydrochloride

VETRANAL®, analytical standard

616559

Fluoxetine-d5 hydrochloride

98 atom % D

CONDITIONS

column

Astec CHIRALDEX B-DA, 10 m x 0.25 mm I.D., 0.12 μm (72021AST)

oven

175 °C

detector

FID, 250 °C

carrier gas

helium, 15 psi

inj. temp.

250 °C

sample

peaks 1 & 2: fluoxetine enantiomers (N-TFA derivatives)

Description

Legal Information

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIRALDEX is a trademark of Sigma-Aldrich Co. LLC

Chromatogram Search

Related Product Categories

HPLC ColumnsGC Columns & AccessoriesTLC Plates & AdsorbentsSolid Phase Microextraction (SPME)Solid Phase Extraction & QuEChERS

Related Applications

Small Molecule HPLCLarge Molecule HPLCGas Chromatography (GC)TLCSolid Phase Microextraction (SPME)Solid Phase Extraction (SPE)QuEChERS